Home/Filings/4/0001193125-25-280766
4//SEC Filing

Yu Jonathan Yen-Wen 4

Accession 0001193125-25-280766

CIK 0001816736other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 8:22 PM ET

Size

13.9 KB

Accession

0001193125-25-280766

Insider Transaction Report

Form 4
Period: 2025-11-11
Yu Jonathan Yen-Wen
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-11$2.65/sh+30,000$79,50070,555 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-1130,0007,941 total
    Exercise: $2.65Exp: 2030-08-10Common Stock (30,000 underlying)
  • Sale

    Common Stock

    2025-11-11$83.15/sh8,015$666,41062,540 total
  • Sale

    Common Stock

    2025-11-11$83.99/sh4,585$385,08457,955 total
  • Sale

    Common Stock

    2025-11-11$85.33/sh9,360$798,69048,595 total
  • Sale

    Common Stock

    2025-11-11$85.91/sh8,040$690,74040,555 total
Footnotes (6)
  • [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 22, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.63 to $83.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.63 to $84.62, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.69 to $85.68, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.69 to $86.28, inclusive.
  • [F6]The shares underlying this option are fully vested and exercisable as of the date hereof.

Documents

1 file

Issuer

Disc Medicine, Inc.

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001951849

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:22 PM ET
Size
13.9 KB